You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Protocols – Radiation Treatment

The following list provides an overview of evidence-based protocols for radiation treatment that are approved for use in Ontario.

For reporting purposes, use the list of active radiation treatment protocols available in the Data Book.

To review recent changes to the radiation treatment protocols, download the Summary of Radiation Treatment Protocol Changes.

To submit a new protocol for review, see Request a New or Modified Protocol.

Radiation QBP

15 items

CNS_ACOUSTIC/SCHW_SRS

CNS- Acoustic neuroma/schwannoma SRS

Cancer Type: Benign (CNS)
Modality: SRS
Dose (Gy):12-25
Fractionation: 1-5
Dose per Fraction(Gy):5-12
Apr 2020

CNS_BRAI_RETX_SRS

CNS- Glioma retreatment- single SRS

Cancer Type: Central Nervous System
Modality: SRS
Dose (Gy):10-20
Fractionation: 1
Dose per Fraction(Gy):10-20
Apr 2020

CNS_BRAI_RETX_SRS_FX

CNS- Glioma retreatment fractionated SRS

Cancer Type: Central Nervous System
Modality: SRS
Dose (Gy):25-35
Fractionation: 5
Dose per Fraction(Gy):5-7
Jun 2021

CNS_BRAIN_MET_SRS_FRAC

CNS Brain Mets- Stereotactic - fractionated

Cancer Type: Any (CNS)
Modality: SRS
Dose (Gy):21-35
Fractionation: 3-5
Dose per Fraction(Gy):5-9
Apr 2020

CNS_BRAIN_MET_SRS_SINGLE

CNS Brain mets- Stereotactic - single fraction

Cancer Type: Any (CNS)
Modality: SRS
Dose (Gy):12-24
Fractionation: 1
Dose per Fraction(Gy):12-24
Apr 2020

CNS_FUNCTIONALPTL_SRS

Non-Neoplastic- CNS-Functional protocol SRS

Cancer Type: Non-Neoplastic (CNS)
Modality: SRS
Dose (Gy):60-150
Fractionation: 1
Dose per Fraction(Gy):60-150
Feb 2021

CNS_MENINGIOMA_SRS

CNS- Meningioma SRS

Cancer Type: Central Nervous System
Modality: SRS
Dose (Gy):12-30
Fractionation: 1-5
Dose per Fraction(Gy):6-15
Apr 2020

CNS_SARC_RETXT_SRS

CNS- Sarcoma retreatment SRS

Cancer Type: Sarcoma (CNS)
Modality: SRS
Dose (Gy):24-40
Fractionation: 1-5
Dose per Fraction(Gy):8-24
Apr 2020

CNS_SARC_SRS

CNS- Sarcoma SRS (includes chordoma and chondrosarcoma)

Cancer Type: Sarcoma (CNS)
Modality: SRS
Dose (Gy):24-40
Fractionation: 1-5
Dose per Fraction(Gy):8-24
Apr 2020

ENDO_PITUITARY_FUNC

CNS Pituitary-Functional pituitary

Cancer Type: Endocrine (CNS)
Modality: SRS
Dose (Gy):15-30
Fractionation: 1
Dose per Fraction(Gy):15-30
Apr 2020

ENDO_PITUITARY_SRS

CNS Pituitary- SRS

Cancer Type: Endocrine (CNS)
Modality: SRS
Dose (Gy):12-30
Fractionation: 1-6
Dose per Fraction(Gy):5-15
Apr 2020

NONNEO_AVMAL_FX

Non-neoplastic (CNS)-Arteriovenous malformations fractionated

Cancer Type: Non-Neoplastic (CNS)
Modality: SRS
Dose (Gy):20-30
Fractionation: 4-5
Dose per Fraction(Gy):5-6
Feb 2021